News

The collaboration, which is subject to the parties entering into a definitive agreement, is designed to provide Medicare beneficiaries who enroll in Medco’s program with broad, affordable access

Ventavis (iloprost) is the newest entry into the prostacyclin class of pulmonary arterial hypertension (PAH) treatments. Prior to the introduction of Ventavis, prostacyclin therapies for PAH required continuous

The preclinical data reveals that, when Davanat is co-administrated with 5-FU and the anti-vascular endothelial growth factor (VEGF) drug, Avastin, to mice implanted with human colon tumor (COLO

The team was led by asthma expert Professor Donna Davies, and Professor Stephen Holgate, an asthma expert and co-founder of Synairgen Plc, a UK drug discovery firm to

Under the terms of the agreement, Japan Tobacco (JT) has granted Gilead exclusive rights to develop and commercialize a novel HIV integrase inhibitor, JTK-303, in all countries of

The Swiss approval covers the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen. Tarceva

Rubella, or German measles, is a viral illness that is spread by sneezing and coughing. Up to 85% of unvaccinated women exposed to the virus in the first

In December 2004, the High Court in London ruled in favor of CAT in the suit regarding royalties of the arthritis drug Humira. However, the Rt Hon Lord

The new study will compare prophylactic combination therapy with Pegasys (peginterferon alfa-2a) and Copegus (ribavirin, USP), with the same combination therapy administered once hepatitis C infection recurs histologically